Girardi, A
A 37-year-old patient with primary Sjogren syndrome, comorbid Hashimoto thyroiditis, and seronegative rheumatoid arthritis was started on semaglutide
Find Your Studio Tirzepatide is a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
If you fly west (gaining hours), it arrives later
J Bone Miner Res 35(8):14151423 [DOI] [PubMed] [Google Scholar] 13.Herrou J, Mabilleau G, Lecerf JM, Thomas T, Biver E, Paccou J (2024) Narrative review of effects of Glucagon-Like Peptide-1 Receptor Agonists on bone health in people living with obesity
It is not a GLP-1 receptor agonist, a weight-loss drug, or a substitute for any prescribed medication, and it is not intended to treat obesity, diabetes, or any other condition